Acute respiratory infection is a leading cause of death in children and contributes to a substantial amount of mortality in geriatric and immunocompromised patients worldwide. Co-infection with multiple organisms is also common within these patient populations and making clinical decisions more complex. To be effective, providers require access to advanced technologies that can detect multiple pathogens at once reducing the chance of false negative test results that can lead to a delayed or incorrect diagnosis and poor clinical outcomes.

Coronavirus Respiratory Panel includes testing for COVID-19…

CUUR Diagnostics quickly identifies all organisms and pathogens in the respiratory tract and potential bacterial antibiotic resistance allowing providers to offer more effective, supportive care while strengthening their antibiotic stewardship programs. In addition, as seasonal demand increases, CUUR Diagnostics can adapt quickly to changing needs for respiratory infection testing in your community, as well as patient age and overall health. With significant overlap of symptoms across infections and an evolving reimbursement landscape, we offer flexible, custom assays to deliver the highest-quality and cost-effective results.